Update on management of seminoma

Abstract

Testicular germ cell tumors and, in particular, seminomas are exquisitely radiation and chemotherapy-sensitive and most presentations are highly curable. In recent years the management focus has been on reducing late sequelae of treatment. For Stage I disease surveillance and adjuvant carboplatin, chemotherapy has become an option. The efficacy of combination chemotherapy has been established for advanced metastatic disease. Through a review of the available literature this article outlines the recent changes in the management of seminoma.

Keywords

• Carboplatin
• chemotherapy
• orchidectomy
• radiotherapy
• seminoma
• surgery
• surveillance
• testicular germ cell tumors